- Clinical Professor
- Office: 295J
- Phone: 401.874.7484
- Email: email@example.com
- Mailing Address: 7 Greenhouse Road, Kingston, RI 02881
Dr. Ward is Clinical Associate Professor and Director of Drug Information Services. The mission of Drug Information Services is twofold: to provide healthcare practitioners with timely, evidence-based drug information to promote the safe, rational use of medications and to serve as a training site for Doctor of Pharmacy students and post-doctoral residents.
Drug information, literature evaluation, biostatistics, women’s health (contraception, pregnancy/lactation, infertility), medication adherence
Director, Drug Information Services
ASHP-accredited Specialty Residency in Drug Information Practice, University Medical Center, Jacksonville FL, 1997-1998
ASHP-accredited Pharmacy Practice Residency, University Medical Center, Jacksonville FL, 1996-1997
Doctor of Pharmacy, University of Pittsburgh, 1996
B.S., Pharmacy, University of Rhode Island, 1994
Phillips JA, Gabay MP, Ficzere C, Ward KE. Curriculum and instructional methods for drug information, literature evaluation, and biostatistics: Survey of U.S. pharmacy schools. Ann Pharmacother 2012;.46:793-801.
Ward KE, Archambault R, Mersfelder TL. Severe adverse skin reactions to NSAIDs and COX-2 inhibitors: a literature review. Am J Health-Syst Pharm 2010;67:2006-13.
Ye Y, Ward KE. The depiction of illness and related matters in two top-ranked primetime network medical dramas in the United States: a content-analysis. J Health Commun 2010;15:555-70.
Bernknopf AC, Karpinski JP, McKeever AL, Peak AS, Smith KM, Smith WD, Timpe EM, Ward KE. Drug Information PRN Opinion Paper: Drug Information: From Education to Practice. Pharmacotherapy 2009;29:331-46.
LaPlante KL, Mersfelder TL, Ward KE, Quilliam BQ. Prevalence of and risk factors for dysglycemia in patients receiving gatifloxacin and levofloxacin in an outpatient setting. Pharmacotherapy 2008;28:82-9.
Ward KE, Mersfelder TL, LaPlante KL. Oritavancin: Structure, activity, pharmacology and experimental therapeutics. Expert Opin Investig Drugs 2006;15:417-29.
Schucker JJ, Ward KE. A Review of hyperphosphatemia and phosphate-binding medications. Am J Health-Syst Pharm 2005;62:2355-61.
Ward KE, Hume AL. Olmesartan (Benicar) for hypertension. Am Family Phys 2005;72:673-4.